Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies

2006 ◽  
Vol 42 (14) ◽  
pp. 2318-2325 ◽  
Author(s):  
R.A. Sharma ◽  
W.P. Steward ◽  
C.A. Daines ◽  
R.D. Knight ◽  
K.J. O’Byrne ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Toxicity Profile ◽  
Solid Malignancies ◽  
Thalidomide Analogue

Phase I Clinical Trial of Irinotecan With Oral Capecitabine in Patients With Gastrointestinal and Other Solid Malignancies

2002 ◽  
Vol 25 (5) ◽  
pp. 528-534 ◽  
Author(s):  
Sanjay Goel ◽  
Minaxi Jhawer ◽  
Lakshmi Rajdev ◽  
Una Hopkins ◽  
Karen Fehn ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Oral Capecitabine ◽  
Solid Malignancies

Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies

2001 ◽  
Vol 48 (5) ◽  
pp. 347-355 ◽  
Author(s):  
Craig A. Bunnell ◽  
Jeffrey G. Supko ◽  
Joseph Eder ◽  
Jeffrey W. Clark ◽  
Thomas J. Lynch ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Adult Patients ◽  
Phase I Clinical Trial ◽  
Solid Malignancies

A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2113-2113
Author(s):  
D. T. Friedman ◽  
S. Goel ◽  
K. Desai ◽  
D. Verdier-Pinard ◽  
A. Kaubisch ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Solid Malignancies

A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2113-2113
Author(s):  
D. T. Friedman ◽  
S. Goel ◽  
K. Desai ◽  
D. Verdier-Pinard ◽  
A. Kaubisch ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Solid Malignancies
Sign in / Sign up

Export Citation Format

Share Document